Compare SU & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SU | COR |
|---|---|---|
| Founded | 1917 | 2001 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Other Pharmaceuticals |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.6B | 68.5B |
| IPO Year | 1998 | 2001 |
| Metric | SU | COR |
|---|---|---|
| Price | $54.21 | $287.49 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 14 |
| Target Price | $81.00 | ★ $390.62 |
| AVG Volume (30 Days) | ★ 4.6M | 1.4M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.53% | 0.77% |
| EPS Growth | N/A | ★ 5.71 |
| EPS | N/A | ★ 11.27 |
| Revenue | N/A | ★ $321,332,819,000.00 |
| Revenue This Year | $9.14 | $8.89 |
| Revenue Next Year | N/A | $6.75 |
| P/E Ratio | ★ $15.79 | $24.94 |
| Revenue Growth | N/A | ★ 9.31 |
| 52 Week Low | $37.23 | $244.82 |
| 52 Week High | $70.29 | $377.54 |
| Indicator | SU | COR |
|---|---|---|
| Relative Strength Index (RSI) | 27.95 | 59.86 |
| Support Level | $42.35 | $285.83 |
| Resistance Level | $57.13 | $326.95 |
| Average True Range (ATR) | 1.64 | 6.08 |
| MACD | -0.75 | 1.77 |
| Stochastic Oscillator | 1.88 | 98.14 |
Suncor Energy Inc is an integrated energy company. The company's operations span the full energy value chain, including oil sands mining and in situ operations, upgrading, offshore production, petroleum refining in Canada and the U.S., marketing and trading, and nationwide PetroCanada retail and wholesale networks delivering reliable energy that fuels economic growth and meets the needs of customers across Canada and globally. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products, & power. The company's operating segments include Oil Sands, Exploration & Production, Refining & Marketing (R&M), & Corporate & eliminations. Geographically, the company generates a majority of its revenue from Canada.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.